Yingke Xinchuang was punished for sales to unqualified customers, and the director's career resume was doubtful

[Global Network Zero Observation] Yingke Xinchuang (Xiamen) Technology Co., Ltd. specializes in the research and development, production and sales of internal diagnostic products, and successfully developed diagnostic product technology platforms such as POCT, enzyme exemption, and biochemistry. Infectious diseases, blood types, respiratory tracts, digestive tracts, heart logo, eugenics, drug abuse, and immune diseases are currently applying for listing.

The British new board of directors includes 6 full-time directors and 3 independent directors. Three of the 6 full-time directors are American. Vice chairman participated in the company's management through the decision -making of the shareholders' meeting and the board of directors.

It is worth noting that "Jiangsu Yingke Xinchuang Medical Technology Co., Ltd. and its associated enterprises" have always been one of the top five customers of Yingke's new innovation. The keywords, but Yingke's new creation did not use this customer as a connection.

Public information shows that Jiangsu Yingke New Medical Technology Co., Ltd. has changed its business scope in 2022, adding second categories of medical device sales, third category of medical device operations in the new business scope; Before the change, the company's business scope includes only one type of medical equipment. The "Jiangsu Yingke New Medical Technology Co., Ltd.", which is an important dealer of Yingke New Creation, does not include whether the second and third categories of medical device operations are not included in the background of the business scope of many years. Yingke's new product sales are super -scope when they are sold? In this regard, Yingke Xinchuang did not reply to the reporter's interview.

According to the publicly announced "Single Source of the Microbial Detection Reagent Procurement Project of Microbiology Testing Reagent Reagents in Suqian City, Jiangsu Province", in this bidding, "Jiangsu Yingke New Medical Technology Co., Ltd." is used as a single source procurement for subcontracting The unit, Yingke Xinchuang is a single source procurement unit of the fifteen package.

The official website of the Xiamen Market Supervision and Administration Bureau also disclosed that in July 2017, the public information on the administrative punishment case issued by the Hai Cang District Market Supervision and Administration Bureau of Xiamen City showed that the British New Creation was suspected of the drug human immune defect virus that it produced. The antibody diagnostic kit (enzyme -linked immunization method) was sold to four unqualified enterprises including Haili Bio. The company's regulations that provide drugs for production and operational behaviors are also punished by administrative penalties.

According to page 76 of the prospectus, Yingke New Chuang has withdrawn a large number of dealers every year, and there are also a large number of new dealers. In 2019 and 2020, the company sells for the dealers who withdrew the dealers who withdrawn for the immunization unit price It is 72.29 yuan/box and 73.78 yuan/box, while the sales price to the newly added dealer at the same time is 66.4 yuan/box and 63.9 yuan/box, which is significantly lower than the sales price of the dealers who exited to the same period; and regardless of whether Is it a new dealer or an withdrawal dealer that year, and the corresponding sales price is significantly lower than the overall average price of Yingke's new enzyme -connected immune products in the same period.

In addition, according to the prospectus, the secretary and chief financial officer of the British -free new board of directors are Ding Hong, who is responsible for the financial management work such as company accounting, project management, and financial analysis, as well as the company's information disclosure, investor management, board of directors and shareholders' meeting organizations Prepare daily affairs. Ding Hong was born in December 1964 and previously graduated from Fujian Radio and Television University in July 1986. From November 1982 to April 1989, he served as a statistician of Xiamen Chemical Medicine Machinery Factory, that is, Ding Hong served as Xiamen Chemical Statistics of the pharmaceutical machinery factory are less than 18 years old, and have graduated from Electric University for 4 years. The public information also shows that the establishment of the Xiamen Chemical Pharmaceutical Machinery Factory was in October 1997, which was 15 years later than Ding Hong's joining the company.

- END -